The Link Between Tumor Cell Mutations and DNA-RNA Hybrids

New research indicates that chromatin and its regulatory factors play a crucial role in preventing the formation of DNA-RNA hybrids, which are linked to genomic instability and cancer.

Abstract plexus DNA oragnic background

Image Credit: Motion Drama/

These hybrids impede replication, leading to increased chromosomal cleavages and collisions between transcription and replication.

The study outlines chromatin as the primary defense mechanism for maintaining genome integrity. This protective function was observed through the analysis of various chromatin remodeling factors’ silencing in tumor cell cultures.

Upon comparing their data with genome databases of tumor cells, researchers identified a correlation between DNA-RNA hybrid-enriched sites and the locations with the highest frequency of mutations in tumor cells.

This groundbreaking discovery establishes a direct association between DNA-RNA hybrids and mutations associated with cancer, suggesting their role as a risk factor in tumor development.

Aguilera's laboratory, known for pioneering studies on the role of DNA-RNA hybrids in genetic instability, not only enhances our understanding of cellular control mechanisms for hybrids and their regulation by epigenetic factors but also proposes the potential use of cellular DNA-RNA hybrid levels as an indicator for assessing carcinogenic risk.

Journal reference:

Bayona-Feliu, A., et al. (2023) The chromatin network helps prevent cancer-associated mutagenesis at transcription-replication conflicts. Nature Communications.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of AZoLifeSciences.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.